These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Recent developments in neurochemical imaging in schizophrenia: an update. Vyas NS; Patel NH; Herscovitch P; Puri BK; Lanzenberger R Curr Med Chem; 2013; 20(3):351-6. PubMed ID: 23157626 [TBL] [Abstract][Full Text] [Related]
4. Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Lieberman JA; Sheitman BB; Kinon BJ Neuropsychopharmacology; 1997 Oct; 17(4):205-29. PubMed ID: 9326746 [TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine regulation of cholangiocarcinoma: A status quo review. Sha M; Cao J; Sun HY; Tong Y; Xia Q Biochim Biophys Acta Rev Cancer; 2019 Aug; 1872(1):66-73. PubMed ID: 31152820 [TBL] [Abstract][Full Text] [Related]
6. Neurotransmitters and hypothalamic hormones in the central nervous system. Brownstein M Fed Proc; 1977 Jun; 36(7):1960-3. PubMed ID: 16784 [No Abstract] [Full Text] [Related]
7. [Investigation of the dopamine dysregulation hypothesis of schizophrenia with neuroimaging techniques]. Szekeres G; Pávics L; Janka Z Ideggyogy Sz; 2002 Jul; 55(7-8):226-32. PubMed ID: 12201230 [TBL] [Abstract][Full Text] [Related]
8. Does the dopamine hypothesis explain schizophrenia? Lau CI; Wang HC; Hsu JL; Liu ME Rev Neurosci; 2013; 24(4):389-400. PubMed ID: 23843581 [TBL] [Abstract][Full Text] [Related]
9. The neurochemistry of human aggression. Yanowitch R; Coccaro EF Adv Genet; 2011; 75():151-69. PubMed ID: 22078480 [TBL] [Abstract][Full Text] [Related]
10. Neurosteroid biosynthesis: enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides. Do Rego JL; Seong JY; Burel D; Leprince J; Luu-The V; Tsutsui K; Tonon MC; Pelletier G; Vaudry H Front Neuroendocrinol; 2009 Aug; 30(3):259-301. PubMed ID: 19505496 [TBL] [Abstract][Full Text] [Related]
11. Biochemistry and the schizophrenia. Old concepts and new hypothesis. Berger PA J Nerv Ment Dis; 1981 Feb; 169(2):90-9. PubMed ID: 7009786 [TBL] [Abstract][Full Text] [Related]
12. New Targets for Schizophrenia Treatment beyond the Dopamine Hypothesis. Yang AC; Tsai SJ Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28771182 [TBL] [Abstract][Full Text] [Related]
13. New neuroendocrine aspects of depression and anxiety. Laakmann G; Hinz A; Neuhauser H Clin Neuropharmacol; 1986; 9 Suppl 4():245-7. PubMed ID: 3105879 [No Abstract] [Full Text] [Related]
14. Single-unit activity of hypothalamic arcuate neurons in brain tissue slices. Effects of anterior pituitary hormones, cholecystokinin-octapeptide, and neurotransmitters. Pan JT; Kow LM; Pfaff DW Neuroendocrinology; 1986; 43(2):189-96. PubMed ID: 2873524 [TBL] [Abstract][Full Text] [Related]
15. Involvement of neuropeptide systems in schizophrenia: human studies. Cáceda R; Kinkead B; Nemeroff CB Int Rev Neurobiol; 2007; 78():327-76. PubMed ID: 17349866 [TBL] [Abstract][Full Text] [Related]